N/A
N=9
LGBTQ-affirmative CBT for Youth
Anxiety Disorders · Depression · LGBTQ
Bottom Line
View on ClinicalTrials.gov: NCT05408858 ↗Enrolled (actual)
9
Serious AEs
0.0%
Results posted
May 2024
Primary outcome: Primary: Client Satisfaction With Treatment — 27.13 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- LGBTQ-affirmative cognitive behavioral group therapy (Behavioral)
- Age
- Pediatric · 12+ yrs
- Sex
- All
- Sponsor
- Yale University
- Primary completion
- Jan 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Client Satisfaction With Treatment |
27.13 | — |
| SECONDARY Session Attendance |
7 | — |
Summary
This study will adapt LGBTQ-affirmative cognitive behavior therapy (CBT) - previously only used with adults - for youth aged 12-17 years. This intervention addresses the pathways through which minority stress compromises lesbian, gay, bisexual, transgender, and queer (LGBTQ) young peoples' mental health. The purpose of this study is to determine if the intervention is acceptable and feasible for LGBTQ youth.
Eligibility Criteria
Inclusion Criteria
- 12-17 years old
- Self-identify as LGBTQ (any diverse sexual orientation and/or gender identity)
- Live in New York, New Jersey, or Connecticut
- Fluent in English
- Meet diagnostic criteria for a DSM-5 internalizing disorder (any depressive, anxiety, obsessive-compulsive, or adjustment disorder)
- Have consistent, weekly access to an Internet-enabled electronic device that allows for video-conferencing
- Availability to attend 10 weekly 90 minute intervention sessions in summer 2021
- Access to a quiet, private place for intervention sessions
- Provision of informed consent from parent/guardian and assent from the youth
Exclusion Criteria
- Evidence of any psychotic or bipolar spectrum diagnosis
- Active suicidality and/or homicidality (defined as active intent or concrete plan, as opposed to passive ideation) or psychiatric hospitalization within the past 6 months
- Significant cognitive impairment (as determined by an intellectual disability screener) or significant developmental disorder (if impairing youth's ability to participate in group therapy)
- Significant behavior disorder (e.g., oppositional defiant disorder, conduct disorder) if impairing youth's ability to participate in group therapy
- Currently in mental health treatment exceeding one day per month
- Received any cognitive-behavioral therapy treatment in the past 12 months
- Unstable psychotropic medications (defined as changes to antidepressant dosage in the past 3 months, or changes to a benzodiazepine dosage in the past month)
Data sourced from ClinicalTrials.gov (NCT05408858). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.